Engineered Protein Ligand Immobilization for Affinity Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Protein ligands immobilized on carriers at single terminal sites are prone to leakage, compromising binding capacity and efficiency in affinity separation matrices.
Innovation Solution
Development of recombinant Protein A variants with specific amino acid substitutions and linkers containing lysine or cysteine residues for multi-site immobilization, maintaining domain structure and enhancing binding capacity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If protein ligands are immobilized on carriers at single terminal sites, then the immobilization process is simple, but the ligands are prone to leakage which compromises binding capacity and efficiency
Solution Approach 1:
The ligand is divided into multiple functional segments: N-terminal region for immobilization, C-terminal region for immobilization, and central antibody-binding domains. This segmentation allows multi-site attachment to the carrier while preserving the central binding function, preventing ligand leakage and improving stability.
Solution Approach 2:
Different regions of the ligand are assigned different functions: the N-terminal and C-terminal regions are optimized for carrier attachment, while the central domains are optimized for antibody binding. This local differentiation ensures that immobilization sites do not interfere with binding sites, maintaining both stability and binding capacity.
2Ease of manufacture
If protein ligands are immobilized on carriers at single terminal sites, then the immobilization method is straightforward, but the binding capacity and efficiency are compromised due to ligand leakage
Solution Approach 1:
The ligand structure is segmented into multiple domains with distinct functions: terminal regions for immobilization and central regions for binding. This allows the ligand to attach at multiple points to the carrier, preventing leakage and maintaining high binding capacity throughout the operational life of the column.
Solution Approach 2:
The ligand functions as a composite structure combining immobilization-capable terminal regions with high-affinity binding domains in the center. This composite design integrates both attachment and binding functions into a single molecular entity, ensuring both stability and high productivity.
3Reliability
If Protein A variants are engineered with amino acid substitutions and linkers for multi-site immobilization, then ligand leakage is reduced and binding capacity is enhanced, but the protein structure and production complexity increase
Solution Approach 1:
The Protein A variant is segmented into functional modules: N-terminal region with immobilization sites, central antibody-binding domains (maintained from wild-type), and C-terminal region with immobilization sites. Linker regions connect these modules. This modular segmentation achieves multi-site immobilization while keeping each module relatively simple and well-defined.
Solution Approach 2:
Specific amino acid substitutions are introduced at terminal regions to create immobilization sites, while the central binding domains are preserved. Linker sequences are designed with specific properties (flexibility, length) to connect domains. These controlled parameter changes achieve the desired functionality without unnecessarily complicating the overall structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel engineered protein ligands achieve high binding capacity and efficiency with reduced ligand leakage, optimizing industrial processes for expensive protein production and antibody purification.
Implementation Method 1
Protein ligand for affinity isolation matrix... proteins capable of specifically binding to a target substance, ligand affinity separation matrices obtained by immobilizing such a protein on a carrier
Data Source
AI summary
An object of the present invention is to develop techniques to create novel engineered protein ligands that maximize the binding capacity and binding efficiency to a target molecule of affinity separation matrices on which the protein ligands are immobilized. The present invention provides protein ligands (variants) that can be immobilized on carriers in a manner shown in schematic FIG. 1(4)-(15), as well as antibody affinity separation matrices obtained by immobilizing such a protein ligand on a water-insoluble carrier. The affinity separation matrices are characterized by their excellent binding capacity and binding efficiency to a target molecule.